most citedMotifBench: A standardized protein design benchmark for motif-scaffolding problems

2 citations · 2 across the 2 of their papers we have counts for

collaborators

6 papers

q-bio.BM2025

Consistent Synthetic Sequences Unlock Structural Diversity in Fully Atomistic De Novo Protein Design

Danny Reidenbach, Zhonglin Cao, Zuobai Zhang +8

High-quality training datasets are crucial for the development of effective protein design models, but existing synthetic datasets often include unfavorable sequence-structure pair…

q-bio.BM2025

Flows, straight but not so fast: Exploring the design space of Rectified Flows in Protein Design

Junhua Chen, Simon Mathis, Charles Harris +2

Generative modeling techniques such as Diffusion and Flow Matching have achieved significant successes in generating designable and diverse protein backbones. However, many current…

cs.LG2025

Compositional Flows for 3D Molecule and Synthesis Pathway Co-design

Tony Shen, Seonghwan Seo, Ross Irwin +4

Many generative applications, such as synthesis-based 3D molecular design, involve constructing compositional objects with continuous features. Here, we introduce Compositional Gen…

cs.LG2025

Proteina: Scaling Flow-based Protein Structure Generative Models

Tomas Geffner, Kieran Didi, Zuobai Zhang +8

Recently, diffusion- and flow-based generative models of protein structures have emerged as a powerful tool for de novo protein design. Here, we develop Proteina, a new large-scale…

cs.LG20252 cited

MotifBench: A standardized protein design benchmark for motif-scaffolding problems

Zhuoqi Zheng, Bo Zhang, Kieran Didi +5

The motif-scaffolding problem is a central task in computational protein design: Given the coordinates of atoms in a geometry chosen to confer a desired biochemical function (a mot…

cs.LG2024

BioNeMo Framework: a modular, high-performance library for AI model development in drug discovery

Peter St. John, Dejun Lin, Polina Binder +89

Artificial Intelligence models encoding biology and chemistry are opening new routes to high-throughput and high-quality in-silico drug development. However, their training increas…